| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
group | 0.600 | None | 1.000 | 1 | 0 | 2004 | 2019 | ||||||||
|
nitric oxide synthase 2 | 0.364 | 0.923 | 4.0E-15 |
|
group | 0.600 | None | 1.000 | 1 | 0 | 1999 | 2018 | ||||||||
|
renin | 0.370 | 0.923 | 2.4E-07 |
|
group | 0.600 | None | 0.969 | 1 | 0 | 1975 | 2020 | ||||||||
|
superoxide dismutase 2 | 0.379 | 0.923 | 0.15 |
|
group | 0.550 | None | 1.000 | 1 | 0 | 2002 | 2019 | ||||||||
|
BRCA1 DNA repair associated | 0.367 | 0.923 | 9.2E-29 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
caspase 8 | 0.404 | 0.923 | 3.7E-06 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
nitric oxide synthase 1 | 0.408 | 0.885 | 1.00 |
|
group | 0.260 | None | 1.000 | 6 | 0 | 2003 | 2017 | ||||||||
|
nitric oxide synthase 3 | 0.378 | 0.885 | 6.7E-07 |
|
group | 0.700 | None | 0.942 | 5 | 0 | 1996 | 2019 | ||||||||
|
peroxisome proliferator activated receptor gamma | 0.358 | 0.885 | 2.9E-02 |
|
group | 0.700 | None | 1.000 | 3 | 0 | 1999 | 2020 | ||||||||
|
endothelin receptor type A | 0.426 | 0.885 | 0.99 |
|
group | 0.600 | None | 1.000 | 2 | 0 | 1996 | 2019 | ||||||||
|
gap junction protein alpha 1 | 0.393 | 0.885 | 0.16 |
|
group | 0.610 | None | 1.000 | 2 | 0 | 2006 | 2017 | ||||||||
|
insulin like growth factor 1 | 0.318 | 0.885 | 0.27 |
|
group | 0.600 | None | 0.931 | 2 | 0 | 1993 | 2020 | ||||||||
|
NADPH oxidase 4 | 0.471 | 0.885 | 5.8E-20 |
|
group | 0.600 | None | 1.000 | 2 | 0 | 2007 | 2019 | ||||||||
|
phosphoinositide-3-kinase regulatory subunit 1 | 0.477 | 0.885 | 1.00 |
|
group | 0.200 | None | 1.000 | 2 | 0 | 2008 | 2009 | ||||||||
|
peroxisome proliferator activated receptor alpha | 0.432 | 0.885 | 3.0E-02 |
|
group | 0.570 | None | 1.000 | 2 | 0 | 2002 | 2018 | ||||||||
|
adenosine deaminase | 0.440 | 0.885 | 2.9E-12 |
|
group | 0.230 | None | 1.000 | 1 | 0 | 1998 | 2019 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
group | 0.230 | None | 1.000 | 1 | 0 | 2005 | 2018 | ||||||||
|
periostin | 0.428 | 0.885 | 1.1E-09 |
|
group | 0.210 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
chitinase 3 like 1 | 0.419 | 0.885 | 1.1E-05 |
|
group | 0.250 | None | 0.833 | 1 | 0 | 2008 | 2020 | ||||||||
|
C-C motif chemokine receptor 5 (gene/pseudogene) | 0.398 | 0.885 | 4.3E-10 |
|
group | 0.230 | None | 1.000 | 1 | 0 | 2010 | 2019 | ||||||||
|
cytochrome b-245 beta chain | 0.452 | 0.885 | 1.00 |
|
group | 0.600 | None | 0.812 | 1 | 0 | 2003 | 2020 | ||||||||
|
cytochrome P450 family 19 subfamily A member 1 | 0.410 | 0.885 | 1.7E-05 |
|
group | 0.260 | None | 0.857 | 1 | 0 | 1993 | 2017 | ||||||||
|
NAD(P)H quinone dehydrogenase 1 | 0.434 | 0.885 | 1.2E-09 |
|
group | 0.220 | None | 1.000 | 1 | 0 | 2011 | 2015 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
group | 0.280 | None | 1.000 | 1 | 0 | 2009 | 2020 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
group | 0.360 | None | 1.000 | 1 | 0 | 2005 | 2020 |